CAV1 and breast cancer: Supporting this hypothesis, breast cancer cells co-expressing Cav-1 and cathepsin B exhibit higher malignancy than other cells owing to their increased invasion and metastasis (40), which is likely attributed to increased secretion of cathepsin B and subsequent extracellular matrix degradation.